Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

HR 484 Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID 19 vaccines or treatments

US Congress 117th Congress

Bill Texts

Introduced 06/18/2021

Weigh In

Spread the Word!

Gettr Embed Code

Sponsors (24)

Rep. Liz Cheney


Co-Sponsor

Rep. Ann Wagner


Co-Sponsor

Rep. Jody B. Hice


Co-Sponsor

Rep. Jim Jordan


Co-Sponsor

Rep. Richard Hudson


Co-Sponsor

Rep. Tom Emmer


Co-Sponsor

Sen. Ted Budd


Co-Sponsor

Rep. Mike Bost


Co-Sponsor

Rep. Bob Gibbs


Co-Sponsor

Rep. John H. Rutherford


Co-Sponsor

Rep. Jeff Duncan


Co-Sponsor

Rep. James Comer


Co-Sponsor

Rep. Ralph W. Norman


Co-Sponsor

Rep. Jeff Van Drew


Co-Sponsor

Rep. Tim Burchett


Co-Sponsor

Rep. Mark Green


Co-Sponsor

Rep. Scott Franklin


Co-Sponsor

Rep. Ashley E. Hinson


Co-Sponsor

Rep. Mariannette J. Miller-Meeks


Primary Sponsor

Rep. Michelle Fischbach


Co-Sponsor

Rep. Nicole Malliotakis


Co-Sponsor

Rep. Nancy Mace


Co-Sponsor

Rep. Ronny Jackson


Co-Sponsor

Rep. Burgess Owens


Co-Sponsor

Track This Bill

Get notified when this bill is updated

Subject(s)

Commerce Cardiovascular And Respiratory Health Competitiveness, Trade Promotion, Trade Deficits Emergency Medical Services And Trauma Care Health Technology, Devices, Supplies Immunology And Vaccination Infectious And Parasitic Diseases Intellectual Property Manufacturing